Lirioresinol B dimethyl ether inhibits NF-κB and COX-2 and activates IκBα expression in CCl4-induced hepatic fibrosis

被引：0
|
作者：
Adeeb Shehzad
Shagufta Rehmat
Salman Ul-Islam
Rizwan Ahmad
Meneerah Aljafary
Noor A. Alrushaid
Ebtesam A. Al-Suhaimi
机构：
[1] Institute for Research and Medical Consultations,Department of Clinical Pharmacy
[2] Imam Abdulrahman Bin Faisal University,Department of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering (SMME)
[3] National University of Sciences and Technology,School of Life Sciences
[4] Kyungpook National University,Natural Products and Alternative Medicines, College of Clinical Pharmacy
[5] Imam Abdulrahman Bin Faisal University,Department of Biology, College of Sciences
[6] Imam Abdulrahman Bin Faisal University,Institute for Research and Medical Consultations
[7] Imam Abdulrahman Bin Faisal University,undefined
来源：
BMC Complementary Medicine and Therapies | / 20卷
关键词：
Inflammation; Lirioresinol B dimethyl ether; Antioxidant; NFκB; COX-2; Hepatic fibrosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Lirioresinol B dimethyl ether inhibits NF-κB and COX-2 and activates IκBα expression in CCl4-induced hepatic fibrosis
    Shehzad, Adeeb
    Rehmat, Shagufta
    Ul-Islam, Salman
    Ahmad, Rizwan
    Aljafary, Meneerah
    Alrushaid, Noor A.
    Al-Suhaimi, Ebtesam A.
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01) : 49
  • [2] Inhibitory effects of salvianolic acid B on CCl4-induced hepatic fibrosis through regulating NF-κB/IκBα signaling
    Wang, Rong
    Yu, Xiao-Yan
    Guo, Zhu-Ying
    Wang, Yu-Jie
    Wu, Yan
    Yuan, Yong-Fang
    JOURNAL OF ETHNOPHARMACOLOGY, 2012, 144 (03) : 592 - 598
  • [3] Selective inactivation of NF-κB in the liver using NF-κB decoy suppresses CCl4-induced liver injury and fibrosis
    Son, Gakuhei
    Iimuro, Yuji
    Seki, Ekihiro
    Hirano, Tadamichi
    Kaneda, Yasufumi
    Fujimoto, Jiro
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 293 (03): : G631 - G639
  • [4] NF-κB "decoy" inhibits COX-2 expression in epileptic rat brain
    Xu, Jing
    Sun, Yiping
    Zhao, Yongshun
    Li, Qifa
    Ge, Biying
    Dai, Shufang
    Liu, Kemin
    Xu, Hong
    Fu, Lei
    Zhao, Jie
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2020, 19 (01) : 77 - 87
  • [5] Bortezomib attenuates CCl4-induced liver fibrosis in rats via regulating NF-κB
    Pan, Wen
    Wu, Jiali
    Chen, Xuping
    Su, Song
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 94 - 94
  • [6] Sulfasalazine prevents the increase in TGF-β, COX-2, nuclear NFκB translocation and fibrosis in CCl4-induced liver cirrhosis in the rat
    Chavez, E.
    Castro-Sanchez, L.
    Shibayama, M.
    Tsutsumi, V.
    Moreno, M. G.
    Muriel, P.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2012, 31 (09) : 913 - 920
  • [7] Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-κB in mouse skin by blocking IκB kinase activity
    Kundu, Joydeb Kumar
    Shin, Young Kee
    Kim, Sung Hoon
    Surh, Young-Joon
    CARCINOGENESIS, 2006, 27 (07) : 1465 - 1474
  • [8] Tanshinol ameliorates CCL4-induced liver fibrosis in rats through the regulation of Nrf2/HO-I and NF-κB/IκBα signaling pathway
    Wang, Rong
    Wang, Jing
    Song, Fuxing
    Li, Shengnan
    Yuan, Yongfang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1281 - 1292
  • [9] HESPERIDIN PREVENTS FIBROSIS BY DECREASING THE EXPRESSION OF NF-κB, TGF-β AND CTGF IN A CCl4-INDUCED LIVER DAMAGE IN RAT
    Perez, E.
    Muriel, P.
    Moreno, M. G.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S213 - S213
  • [10] Corn oligopeptides inhibit Akt/NF-κB signaling pathway and inflammatory factors to ameliorate CCl4-induced hepatic fibrosis in mice
    Feng, Xiao-Wen
    Cheng, Qing-Li
    Fang, Lei
    Liu, Wen-Ying
    Liu, Liang-Wei
    Sun, Chuan-Qiang
    Lu, Zhi-Hao
    Li, Guo-Ming
    Gu, Rui-Zeng
    JOURNAL OF FOOD BIOCHEMISTRY, 2022, 46 (08)
12345